Decahydro-1H-indenoquinoline and decahydro-3H-cyclopentaphenanthridinone CYP17 inhibitor

摘要

Provided herein are inhibitors of CYP17 enzyme. Also described herein are pharmaceutical compositions that include at least one compound described herein and the use of a compound or pharmaceutical composition described herein to treat androgen-dependent diseases, disorders and conditions.